167 related articles for article (PubMed ID: 8622644)
1. Ability of nondepolarizing neuromuscular blocking drugs to act as partial agonists at fetal and adult mouse muscle nicotinic receptors.
Fletcher GH; Steinbach JH
Mol Pharmacol; 1996 May; 49(5):938-47. PubMed ID: 8622644
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characteristics of the inhibition of nondepolarizing neuromuscular blocking agents at human adult muscle nicotinic acetylcholine receptor.
Jonsson Fagerlund M; Dabrowski M; Eriksson LI
Anesthesiology; 2009 Jun; 110(6):1244-52. PubMed ID: 19417616
[TBL] [Abstract][Full Text] [Related]
3. Roles of amino acids and subunits in determining the inhibition of nicotinic acetylcholine receptors by competitive antagonists.
Dilger JP; Vidal AM; Liu M; Mettewie C; Suzuki T; Pham A; Demazumder D
Anesthesiology; 2007 Jun; 106(6):1186-95. PubMed ID: 17525594
[TBL] [Abstract][Full Text] [Related]
4. Site selectivity of competitive antagonists for the mouse adult muscle nicotinic acetylcholine receptor.
Liu M; Dilger JP
Mol Pharmacol; 2009 Jan; 75(1):166-73. PubMed ID: 18842832
[TBL] [Abstract][Full Text] [Related]
5. The actions of muscle relaxants at nicotinic acetylcholine receptor isoforms.
Garland CM; Foreman RC; Chad JE; Holden-Dye L; Walker RJ
Eur J Pharmacol; 1998 Sep; 357(1):83-92. PubMed ID: 9788777
[TBL] [Abstract][Full Text] [Related]
6. Open channel and competitive block of nicotinic receptors by pancuronium and atracurium.
Löwenick CV; Krampfl K; Schneck H; Kochs E; Bufler J
Eur J Pharmacol; 2001 Feb; 413(1):31-5. PubMed ID: 11173060
[TBL] [Abstract][Full Text] [Related]
7. The effect of local anesthetics on the inhibition of adult muscle-type nicotinic acetylcholine receptors by nondepolarizing muscle relaxants.
Wang H; Zhang Y; Li ST
Eur J Pharmacol; 2010 Mar; 630(1-3):29-33. PubMed ID: 20045405
[TBL] [Abstract][Full Text] [Related]
8. The effect of non-depolarizing neuromuscular blocking agents on the release of acetylcholine from the right atrium of the guinea pig.
Manabe N
Acta Med Okayama; 1997 Feb; 51(1):13-8. PubMed ID: 9057930
[TBL] [Abstract][Full Text] [Related]
9. The potency of new muscle relaxants on recombinant muscle-type acetylcholine receptors.
Paul M; Kindler CH; Fokt RM; Dresser MJ; Dipp NC; Yost CS
Anesth Analg; 2002 Mar; 94(3):597-603; table of contents. PubMed ID: 11867382
[TBL] [Abstract][Full Text] [Related]
10. Antagonist and partial agonist actions of d-tubocurarine at mammalian muscle acetylcholine receptors.
Steinbach JH; Chen Q
J Neurosci; 1995 Jan; 15(1 Pt 1):230-40. PubMed ID: 7529826
[TBL] [Abstract][Full Text] [Related]
11. Distinct pharmacologic properties of neuromuscular blocking agents on human neuronal nicotinic acetylcholine receptors: a possible explanation for the train-of-four fade.
Jonsson M; Gurley D; Dabrowski M; Larsson O; Johnson EC; Eriksson LI
Anesthesiology; 2006 Sep; 105(3):521-33. PubMed ID: 16931985
[TBL] [Abstract][Full Text] [Related]
12. Galantamine activates muscle-type nicotinic acetylcholine receptors without binding to the acetylcholine-binding site.
Akk G; Steinbach JH
J Neurosci; 2005 Feb; 25(8):1992-2001. PubMed ID: 15728839
[TBL] [Abstract][Full Text] [Related]
13. Interaction among agents that block end-plate depolarization competitively.
Waud BE; Waud DR
Anesthesiology; 1985 Jul; 63(1):4-15. PubMed ID: 2409846
[TBL] [Abstract][Full Text] [Related]
14. Nondepolarizing neuromuscular blockers inhibit the serotonin-type 3A receptor expressed in Xenopus oocytes.
Min KT; Wu CL; Yang J
Anesth Analg; 2000 Feb; 90(2):476-81. PubMed ID: 10648343
[TBL] [Abstract][Full Text] [Related]
15. Interactions of the thymic polypeptide hormone thymopoietin with neuronal nicotinic alpha-bungarotoxin binding sites and with muscle-type, but not ganglia-type, nicotinic acetylcholine receptor ligand-gated ion channels.
Lukas RJ; Audhya T; Goldstein G; Lucero L
Mol Pharmacol; 1990 Dec; 38(6):887-94. PubMed ID: 1701215
[TBL] [Abstract][Full Text] [Related]
16. Activation of endplate nicotinic acetylcholine receptors by agonists.
Auerbach A
Biochem Pharmacol; 2015 Oct; 97(4):601-608. PubMed ID: 26206191
[TBL] [Abstract][Full Text] [Related]
17. Isobolographic analysis of non-depolarising muscle relaxant interactions at their receptor site.
Paul M; Kindler CH; Fokt RM; Dipp NC; Yost CS
Eur J Pharmacol; 2002 Mar; 438(1-2):35-43. PubMed ID: 11906708
[TBL] [Abstract][Full Text] [Related]
18. Blockage of mouse muscle nicotinic receptors by serotonergic compounds.
García-Colunga J; Miledi R
Exp Physiol; 1999 Sep; 84(5):847-64. PubMed ID: 10502654
[TBL] [Abstract][Full Text] [Related]
19. Additive inhibition of nicotinic acetylcholine receptors by corticosteroids and the neuromuscular blocking drug vecuronium.
Kindler CH; Verotta D; Gray AT; Gropper MA; Yost CS
Anesthesiology; 2000 Mar; 92(3):821-32. PubMed ID: 10719961
[TBL] [Abstract][Full Text] [Related]
20. Potency of agonists and competitive antagonists on adult- and fetal-type nicotinic acetylcholine receptors.
Yost CS; Winegar BD
Cell Mol Neurobiol; 1997 Feb; 17(1):35-50. PubMed ID: 9118208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
